Cormorant Asset Management »

Abivax SA F shares owned by Cormorant Asset Management

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by Cormorant Asset Management from 13F filings

Historical chart of Cormorant Asset Management investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by Cormorant Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $28M 2.1M 13.22
2024-03-31 $31M 2.1M 14.30
2023-12-31 $23M 2.1M 10.70

More positions owned by Cormorant Asset Management

Moonlake Immunotherapeutics Class A Ord (MLTX)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Arcellx Common Stock (ACLX)
Vaxcyte (PCVX)
Longboard Pharmaceuticals In (LBPH)
Eyepoint Pharmaceuticals Com New (EYPT)
Rapport Therapeutics (RAPP)
Crinetics Pharmaceuticals In (CRNX)
Edgewise Therapeutics (EWTX)
Merus N V (MRUS)
Bridgebio Pharma (BBIO)
Insmed Com Par $.01 (INSM)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Janux Therapeutics (JANX)
Axsome Therapeutics (AXSM)

View all positions for Cormorant Asset Management

Top funds holding Abivax SA F

TCG Crossover Management
Deep Track Capital
Cormorant Asset Management
Dr. Jeffrey R. Jay, M.D.
Blackstone Group
VR Adviser
Franklin Resources
Commodore Capital
Henderson Group
Nantahala Capital Management
Samsara BioCapital
Saturn V Capital Management
Morgan Stanley
Point72 Asset Management
Citadel Advisors

View all funds holding Abivax SA F